What Are The Best Psychedelic-Assisted Therapy Clinics In The World? Here Are 5 To Check Out
Psychedelic-Assisted Therapy, or PAT, is the type of treatment in which the delivery of a psychedelic substance -i.e.
Atai’s Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
Clinical stage psychedelics company atai Life Sciences (NASDAQ: ATAI) and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing the safety and efficacy of a single intravenous infusion (IV) dose of proprietary R-ketamine PCN-101 for patients
Silo Wellness And Marley Green Terminate Licensing Deal Over Insufficient Sales
A five-year license agreement signed between Silo Wellness Inc.’s (OTCQB: SILFF) wholly-owned subsidiary SW Holdings Inc.
Canadian Company’s New Version Of Chemo-Induced Pain Treatment Is On FDA Track
Drug delivery company IntelGenx Corp.
Psyched:DEA Boosts Research Production, Booker’s Psychedelics Reform, Kanye West’s George Floyd Comments And More
DEA Boosts Production Of Cannabis & Psychedelics For Research In 2023
The DEA is proposing that 6.7 million grams (14,770 pounds) of marijuana be grown for research, more than double the amount suggested for 2022 (3.2 million grams).
Canada Update: Psychedelics Legal Landscape, Overview & Near-Term Predictions
Canada is hosting discussions on legal access to psychedelic-assisted therapies, especially after Alberta passed regulatory measures for this type of health s
Fmr. Deutsche Bank CEO & Real Madrid’s Toni Kroos Invest In A Psychedelics Company’s $14M Funding Round
US and German-based HMNC Brain Health (HMNC Holding GmbH), a clinical stage biopharma company pioneering precision psychiatry, has raised nearly $14 million (EUR 14.3 million) in the closing of the first of two expected funding series, bringing the total capital raised to date to over $41 million (EUR 42.3 million.) The second closing of this round would be completed by the end
NGOs Raise Money To Help Stem Opioid Addiction With Psychedelics Program
The 100 Million Ways Foundation (100MW), a not-for-profit organization focused on harm reduction and improving quality of life of those with opioid use disorders, pulled in nearly $100,000 in fundraising at a recent gala commemorating the work carried out so far.
This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More
Short-acting psychedelics biotech firm Small Pharma Inc.
